MRT68921: Precision Dual ULK1/2 Kinase Inhibitor for Autophagy Research

Executive Summary: MRT68921 (SKU B6174) is a potent, dual inhibitor targeting the autophagy-related serine/threonine kinases ULK1 and ULK2, with nanomolar IC50 values (2.9 nM for ULK1, 1.1 nM for ULK2), enabling precise pharmacological blockade of autophagy initiation (APExBIO). The compound effectively inhibits ATG13 phosphorylation and LC3 flux in wild-type cell lines, providing a measurable readout of autophagy suppression (Park et al., 2023). MRT68921 displays high selectivity, though it also inhibits TBK1/IKK and AMPK-related kinases (>80%), yet these off-targets are not implicated in its autophagy-blocking effect. Solubility is limited to DMSO at ≥2.18 mg/mL, and storage at -20°C is required. No in vivo or clinical data exist as of June 2024; the compound is for research use only. (APExBIO)

Biological Rationale

Autophagy is a conserved eukaryotic process that degrades and recycles cytoplasmic components, critical for cellular homeostasis, especially under nutrient and energy stress (Park et al., 2023). The ULK1 kinase complex initiates autophagy in response to upstream nutrient-sensing pathways, such as mTORC1 and AMPK. mTORC1 inhibits autophagy under nutrient-rich conditions by suppressing ULK1 activity, while AMPK's role is now recognized as context-dependent, restraining abrupt autophagy induction during energy crisis and preserving autophagy components (Park et al., 2023). Pharmacological inhibitors like MRT68921 allow precise dissection of the autophagy signaling pathway, facilitating studies in cancer, neurodegenerative, and metabolic disease models (EPGLabs).

Mechanism of Action of MRT68921 dual autophagy kinase ULK1/2 inhibitor

MRT68921 binds competitively to the ATP-binding pocket of ULK1 and ULK2, inhibiting their kinase activity. This dual inhibition blocks phosphorylation of direct ULK1 substrates such as ATG13 (at Ser318 in human), a key step for autophagosome formation (Park et al., 2023). In cell-based assays, MRT68921 reduces ATG13 phosphorylation and LC3-II flux, classic markers of autophagy initiation. In cells harboring a ULK1 M92T mutant, this inhibitory effect is abrogated, confirming selectivity (APExBIO). While MRT68921 also inhibits TBK1/IKK and several AMPK-related kinases in vitro (>80% inhibition at screening concentrations), these kinases are not directly linked to autophagy initiation in the cellular context of standard assays.

Evidence & Benchmarks

• MRT68921 inhibits ULK1 kinase activity with an IC50 of 2.9 nM and ULK2 with an IC50 of 1.1 nM in biochemical assays (APExBIO, product page).
• MRT68921 blocks ATG13 phosphorylation and LC3 flux in wild-type cells but not in cells expressing the mutant ULK1 (M92T), demonstrating on-target activity (DOI).
• AMPK activation inhibits, rather than promotes, ULK1-mediated autophagy initiation under energy stress, clarifying previous misconceptions about AMPK-ULK1 interaction (Park et al., 2023).
• The compound is insoluble in water and ethanol but achieves solubility ≥2.18 mg/mL in DMSO with gentle warming and sonication (APExBIO, product sheet).
• No published in vivo animal studies or clinical data exist as of June 2024 (APExBIO, product page).

For deeper protocol insights, see this article (details molecular mechanism and assay design), which this review extends by benchmarking against the latest AMPK-ULK1 literature. See also MRT68921 (SKU B6174): Reliable ULK1/2 Inhibition for Autophagy Assays for practical laboratory troubleshooting; this article clarifies selectivity and mechanistic boundaries. For a perspective on energy stress and signaling context, refer to this analysis, which our current review updates with new AMPK data.

Applications, Limits & Misconceptions

MRT68921 is intended exclusively for in vitro and cell-based autophagy pathway research. It is not validated for diagnostic, therapeutic, or in vivo animal use. Key applications include:

• Quantitative assessment of ULK1/2 function in autophagy signaling.
• ATG13 phosphorylation and LC3-II flux assay development.
• Dissection of mTOR-dependent and AMPK-dependent autophagy regulation.
• Preclinical drug discovery in oncology, neurodegeneration, and metabolic disease models.

Common Pitfalls or Misconceptions

• MRT68921 does not induce autophagy; it is a selective inhibitor, not an activator.
• Off-target inhibition of TBK1/IKK and AMPK-related kinases occurs at high concentrations, but these effects do not account for autophagy blockade in standard cell models (Park et al., 2023).
• No in vivo pharmacokinetic or efficacy data are available—translation to animal or human models is untested.
• Compound is insoluble in aqueous buffers; improper dissolution or storage can reduce potency.
• Autophagy readouts (e.g., LC3-II levels) can be confounded by flux blockers or lysosomal inhibitors; use appropriate controls.

Workflow Integration & Parameters

For optimal use of MRT68921:

• Dissolve powder in DMSO to ≥2.18 mg/mL using gentle warming and sonication (APExBIO).
• Store DMSO stock solutions at -20°C; avoid repeated freeze-thaw cycles.
• Standard working concentrations range from 10 nM to 1 μM, depending on cell type and endpoint assay.
• Include wild-type and ULK1 mutant (e.g., M92T) controls to confirm on-target activity.
• Monitor ATG13 phosphorylation and LC3 flux as primary outcome measures.

For troubleshooting and protocol optimization, see the detailed Q&A in this guide—this article further clarifies selectivity and context-dependent limitations of MRT68921.

Conclusion & Outlook

MRT68921, supplied by APExBIO, enables precise and reproducible inhibition of the ULK1/2 kinases, advancing autophagy research in vitro. It is a benchmark tool for dissecting autophagy initiation, with robust data supporting its selectivity and efficacy in cell-based assays. The compound is best suited for mechanistic studies and early-phase drug discovery, with future needs centered on in vivo validation and clinical translation. Researchers should adhere to recommended storage, solubility, and control guidelines to maximize reproducibility. For the latest product specifications and ordering information, visit the MRT68921 dual autophagy kinase ULK1/2 inhibitor page.